Gynuity Health Projects
@Gynuity
Followers
993
Following
2K
Media
335
Statuses
1K
Reproductive & maternal health │Nonprofit with 20 plus years' experience generating & promoting evidence to guide policy & inspire innovative practice
New York, NY
Joined October 2014
We're taking an indefinite break from Twitter/X. Find us on Bluesky and LinkedIn. Keep up to date with our work through our website https://t.co/1P8pH8mYrR
0
0
0
A double dose of the emergency contraceptive ella along with #misoprostol is effective for early abortion, says new study from @Gynuity . @Plancpills
msmagazine.com
Ulipristal acetate, emergency contraceptive, could offer an alternative medication abortion—but it might fuel efforts to restrict Ella/Plan B.
0
5
5
📢 Data from a small study suggest ulipristal acetate plus #misoprotol was effective and safe for early #medicationabortion up to 63 days’ gestation, 💊 but more research is needed. @NEJMEvidence @Gynuity
https://t.co/NLsG2qAY8n
healio.com
Ulipristal acetate followed by misoprostol was effective and acceptable for medication abortion up to 63 days’ gestation with no serious adverse events, but more studies are needed, data from a...
0
1
1
Estamos muy orgullosas(os) de presentar los resultados de un estudio colaborativo publicado en @NEJMEvidence que evalúa la posibilidad de #ulipristal en lugar de #mifepristona en un régimen combinado con #misoprostol para #abortoconmedicamentos -- https://t.co/dcGI2n0P6z
evidence.nejm.org
The current regimen for early medication abortion in many countries is mifepristone and misoprostol, but mifepristone is relatively expensive and limited in many regions. Ulipristal acetate, with a...
0
0
1
We're proud to present the results from a collaborative study assessing the possibility of #ulipristal instead of #mifepristone in a combined regimen with #misoprostol for #medicationabortion. @OPTinnovate. Article published in @NEJMEvidence -- https://t.co/dcGI2n0P6z
0
0
2
An insight into the birth preferences on women being induced in an Indian government hospital. Fascinating project to be involved with - thanks to Lydia Hawker and colleagues at @AIIMSNagpur @Gynuity @GMCNagpur @LightlyKate @kingdon_carol @LivUniMedicine @LivUni
0
4
12
Induction of labor is an increasingly common intervention but experiences & preferences of induction methods are under-researched. Understanding these perspectives is important to improve the childbirth experience: https://t.co/DMojOePcSK in @AjogGlobal
1
2
4
🧐 https://t.co/RoYH14ALbT ➡️Published studies on #telemedicine medication #abortion & labor induction with oral #misoprostol for #hypertension in pregnancy ➡️Ongoing research on alternative abortifacients, ‘period pill’ regimens & a #postpartum self-care monitoring app
0
0
0
Spoiler Alert. #Telemedicine medication abortion without in-person tests is safe, feasible and acceptable, according to our study in Ukraine, Uzbekistan, and Azerbaijan >> https://t.co/pUlYvaMlM3
0
1
0
Today is #WorldPreeclampsiaDay. Check out the latest evidence on the use of low-dose oral #misoprostol tablets for labor induction in pregnancies complicated by #hypertension. Randomized trial results hot off the press➡️ https://t.co/eM7QcxUfDn
0
2
4
Can you replace oxytocin infusion with oral misoprostol tablets when inducing labour? See the evidence from our multicentre randomised trial published today in BJOG. @NIHRresearch @The_MRC @LivUni @wellcometrust @WHO @Gynuity @LiverpoolWomens
obgyn.onlinelibrary.wiley.com
Objective To assess whether, in those requiring continuing uterine stimulation after cervical ripening with oral misoprostol and membrane rupture, augmentation with low-dose oral misoprostol is...
0
2
8
A study published in #BMCMedResMethodol introduces PaGES: a Participant-Generated Experience and Satisfaction Index, a new Patient-Reported Outcomes or Experience Measures (PROMS/PREMS) evaluation tool. https://t.co/TciFXOtYYI
0
1
1
Opportunities for philanthropic support of #abortion access and #reproductive rights. @BridgespanGroup Overview: https://t.co/ILJD8a62M3. Find @Gynuity alongside @avowtx @avowtexas @Guttmacher @nirhealth @SocietyFP under orgs that advance repro rights, justice and field building
0
0
2
We're delighted to add Tanzania to our Map of #Mifepristone Approvals— https://t.co/lH7ObSWBib. We congratulate everyone involved in getting mifepristone approved, a decision that will help strengthen access to #reproductive healthcare options for individuals in Tanzania.
0
0
0
In a conversation w/ @themeteor, the Council's @lisabhaddad & @Gynuity's Beverly Winikoff discuss #mifepristone, the politics behind targeting the FDA’s approval of the abortion pill, & how the #SCOTUS decision may impact #reprohealth in the US. Read:
wearethemeteor.com
But the case itself is farfetched, argues Dr. Lisa Haddad, the medical director for the Population Council’s Center for Biomedical Research, the nonprofit research center that led clinical testing on...
0
4
5
👉🏽Beverly Winikoff @Gynuity: "no matter the outcome at the Supreme Court, medication abortion is here to stay" 💚via @andrew_chung_ @Reuters
https://t.co/nggqIrXVfv
reuters.com
The abortion opponents who are seeking to convince the U.S. Supreme Court to limit access to the abortion pill mifepristone point to three studies by Gynuity Health Projects, a New York-based women's...
0
1
2
🧐 https://t.co/z25yY8oeDt 👉Medication abortion screening by computer 👉Experiences & satisfaction with childbirth tool 👉Assessing misoprostol-only for #telemedicine #medicationabortion 👉Reproductive health #self-care in humanitarian & fragile settings 👉#SCOTUS amicus brief
0
0
0
👏👏👏Senators in France overwhelmingly approve the inclusion in the Constitution of the "guaranteed freedom" of women "to have recourse to a voluntary termination of pregnancy", paving the way for final adoption of the text in Congress next month.
0
0
0
We applaud Ecuador's Ministry of Health for successfully including mifepristone in its National Essential Medicines List, as well as those who helped make it happen. Map available in Spanish https://t.co/IndS8uDDAh
0
6
13